Uncover key drivers, emerging technologies, and competitive movements shaping the tumor models market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Tumor Models Market?

The tumor model market has seen swift expansion over recent years. It is forecast to increase from $1.92 billion in 2024 to $2.13 billion in 2025, at a compound annual growth rate (CAGR) of 11.3%. This historical growth can be linked to factors such as a rise in cancer cases, increasing requests for personalized medicine, a greater requirement for enhanced preclinical predictability, the growing application of patient-derived xenograft models, and an expanding reliance on in vivo efficacy data.

The tumor model market size is projected for substantial growth in the coming years. It is expected to expand to $3.23 billion by 2029, at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period can be attributed to an increasing focus on human-relevant models, a rising demand for precision oncology, the proliferation of immuno-oncology, a growing need for high-throughput screening models, and an expanding interest in rare cancer models. Significant trends for the forecast period include the evolution of three-dimensional (3D) cell culture models, advancements in pharmaceutical research and developments, progress in cell culture technology, the integration of AI in cancer modelling, and the development of patient-derived organoids.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Industry Forces Are Driving The Tumor Models Market Forward?

The expansion of the tumor models market is anticipated to be driven by the increasing need for personalized medicine. This approach, personalized medicine, involves utilizing an individual’s genetic and lifestyle data to customize treatments and healthcare services according to their unique requirements. Its increasing prominence stems from individuals’ preference for health technologies that provide real-time monitoring and therapeutic strategies specifically adapted to their distinct biological makeup. Tumor models support personalized medicine by serving as experimental platforms that replicate the behavior of actual human cancers, thereby enabling researchers and clinicians to test and forecast how tumors from individual patients will react to particular treatments, leading to a more customized therapeutic strategy. As an illustration, the Personalized Medicine Coalition, a US-based professional membership organization, reported in February 2023 that in 2022, the authorization of 12 novel personalized medicines constituted roughly 34% of all newly approved therapies, marking a significant rise compared to prior years. Consequently, the escalating demand for personalized medicine is propelling the expansion of the tumor models market.

How Is The Tumor Models Market Organized By Different Segments?

The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Current And Upcoming Trends Are Shaping The Tumor Models Market?

Leading companies in the tumor models market are prioritizing the development of sophisticated solutions, particularly tumor spheroid models, to boost the physiological relevance and predictive accuracy of in vitro cancer studies. Tumor spheroid models are defined as three-dimensional (3D) collections of cancer cells that spontaneously create spherical formations in culture. For example, in June 2024, Predictive Oncology, a US-based company providing advanced 3D cell culture technologies and predictive oncology solutions, unveiled a new 3D cell technology to expedite cancer therapeutic drug discovery. This technology incorporates distinctive features such as advanced 3D tumor spheroid and organoid models that closely emulate the tumor microenvironment, high-throughput screening capacities for swift drug testing, provisions for patient-derived personalized tumor models, detailed examination of drug penetration within 3D structures, and seamless integration with AI-driven data analytics to improve predictive accuracy and generate deeper insights into therapeutic responses.

Who Are The Primary Market Leaders In The Tumor Models Market?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

How Do Regional Dynamics Influence The Tumor Models Market Performance?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2025, By The Business Research Company

Voice Payment Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Commerce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Payments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/payments-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model